EGL-121, a first-in-human phase 1/2 trial of EGL-001 in adult patients with selected advanced and/or metastatic solid tumors.

Authors: Thiziri Nait Achour, Sofia Giacosa, Florence Wastelin, Florence Lair, Reno Winter, Bernard Vanhove, Fiorella Kotsias, Pejvack Motlagh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps2672

Source: Full article

---

Abstract

TPS2672